Côte d'Ivoire vs Iraq: Previously treated cases tested for RR-/MDR-TB
Côte d'Ivoire
100.0%
in 2024
Iraq
100.0%
in 2024
Côte d'Ivoire rank
1st
Iraq rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Côte d'Ivoire
- Iraq
How they compare
Côte d'Ivoire currently reports 100.0% against 100.0% in Iraq, a difference of 0.0%.
The two have swapped places 4 times across 16 shared years of data; in 2008 it was Iraq ahead.
Côte d'Ivoire ranks 1st and Iraq ranks 1st of 180 countries.
Across the 3 decades both report, Côte d'Ivoire averaged higher in 1 and Iraq in 2.
Head to head by decade
| Decade | Côte d'Ivoire | Iraq | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.8% | 23.5% | 10.7% | Iraq |
| 2010s | 60.3% | 63.2% | 2.9% | Iraq |
| 2020s | 98.4% | 97.6% | 0.8% | Côte d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Côte d'Ivoire or Iraq?
- Côte d'Ivoire, at 100.0% against 100.0% in Iraq as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Côte d'Ivoire and Iraq?
- 0.0%, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Iraq?
- 16 years are reported by both, from 2008 to 2024.
- How do Côte d'Ivoire and Iraq rank globally for previously treated cases tested for rr-/mdr-tb?
- Côte d'Ivoire ranks 1st and Iraq ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.